COMMUNIQUÉS West-GlobeNewswire

Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
08/05/2025
-- Company delivers on mission to transform women’s health with innovative solutions, including FemaSeed ® for first-line infertility treatment and FemBloc ® non-surgical permanent birth control (full system approval [...]
Keros Reinforces Commitment to Maximizing Stockholder Value
08/05/2025
Responds to Recent Public Stockholder Communications Urges Stockholders to Protect Their Investment by Voting “FOR” the Company’s Highly Qualified Director Nominees LEXINGTON, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- [...]
Genmab Announces Financial Results for the First Quarter of 2024
08/05/2025
May 8, 2025 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2025 Highlights EPKINLY ® (epcoritamab) approved by the Japan Ministry of Health, Labour and Welfare (MHLW) for additional indication [...]
Acentra Health Supports Utah in Securing CMS Certification for Medicaid Enterprise System Modernization
08/05/2025
Milestone highlights Acentra Health’s pivotal role in supporting state Medicaid modernization and eligibility platform transformation MCLEAN, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology and [...]
Kriya Presents Data at the 2025 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
08/05/2025
– Preclinical data support clinical development of KRIYA-825; Phase 1/2 clinical trial in Geographic Atrophy currently underway – – Kriya is developing KRIYA-825 as a potential one-time gene therapy, delivered by [...]
Press release: Transparency Notification from Shareholders
08/05/2025
Transparency Notification from Shareholders Ghent, Belgium – 8 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of drug-resistant fluid [...]
Clue Launches "Connect the Dots" Campaign for Mental Health Awareness Month, Highlighting the Critical Link Between Menstrual Cycles and Mental Wellbeing
08/05/2025
BERLIN, May 08, 2025 (GLOBE NEWSWIRE) -- Clue , the most trusted, data-driven period and reproductive health tracking app, today announced its "Connect the Dots" campaign for Mental Health Awareness Month. The campaign [...]
Philips shareholders approve all proposals at the AGM 2025
08/05/2025
May 8, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The re- [...]
Mapping the Code of Life: European Wellness Highlights 400+ Human Cell Types in Landmark Cytology Atlas
08/05/2025
HEIDELBERG, Germany , May 08, 2025 (GLOBE NEWSWIRE) -- A landmark scientific breakthrough has mapped over 400 human cell types — offering powerful confirmation for the precision medicine philosophy Prof. Mike Chan has [...]
Cuprina Holdings Announces Closing of Underwriter’s Over-Allotment Option in Connection with Initial Public Offering
08/05/2025
SINGAPORE, May 08, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“ Cuprina ” or “the Company ”), a biomedical and biotechnology company dedicated to the development and commercialization of [...]
The Foundation for Sarcoidosis Research Expands Board of Directors with Leaders to Help Accelerate Sarcoidosis Research, Advocacy and Patient Support
08/05/2025
CHICAGO, May 08, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce the appointment of four new members to its Board of Directors: John Mockovciak III, Joan Levy, PhD, John [...]
Yamo Pharma Presents Statistically Significant Phase 2 Autism Results for L1-79 at INSAR 2025
08/05/2025
Trial achieves unprecedented and clinically meaningful socialization gains in adolescents and young adults, addressing core autism symptoms currently lacking FDA-approved therapies NEW YORK, May 08, 2025 (GLOBE NEWSWIRE [...]
STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference
08/05/2025
HORSHAM, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
Arialief Complaints Exposed: 2025 User Reviews Analyzed and Verified
08/05/2025
Arialief for Neuropathy is a doctor-recommended joint support supplement made with natural, clinically backed ingredients like turmeric, glucosamine, and Boswellia. Designed to reduce inflammation, relieve joint pain, [...]
Adial Pharmaceuticals Granted End of Phase 2 Meeting from the U.S. Food and Drug Administration
08/05/2025
Meeting to Take Place on July 25, 2025 Meeting’s Purpose is To Discuss Upcoming Clinical Development Plan and Protocol Designs GLEN ALLEN, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL [...]
Exagen Inc. Prices Public Offering of Common Stock
08/05/2025
CARLSBAD, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the pricing of its previously announced underwritten public offering of 3 [...]
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
08/05/2025
Three-year program examined opportunities to integrate artificial intelligence technology into future generations of ReWalk Exoskeletons MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- [...]
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset
08/05/2025
New patent filing secures composition of matter protection for AZD5904, a potent myeloperoxidase inhibitor in Conduit’s pipeline, unlocking up to 20 years of new IP runway and enabling enhanced formulation strategies to [...]
ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
08/05/2025
Following announcement of prioritized development strategy for evorpacept in combination with anti-cancer antibodies at R&D Day in March, Company is on track to initiate Phase 2 ASPEN-Breast and Phase 1 ASPEN-CRC [...]

Pages